Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating paclitaxel plus carboplatin with or without SCH-58500 in newly diagnosed stage III ovarian cancer or stage III primary peritoneal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• SCH-58500 (SCH-58500)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2, Phase 3 | Status: TERMINATED